Latin American Journal of Pharmacy



 
 
 Vol. 37 Nş 7
Lat. Am. J. Pharm. 37 (7): 1273-1484 (2018)  


REGULAR ARTICLES
 
Metabolism-Mediated Adverse Effects of Tumor-Treatment Herbs  *
YANG L., MENG X., HOU Y., QI Y., XU L. & WANG X.  (1279)
 
 
Determination of a Novel Curcumin Derivative in Rat Plasma by UPLC and its Application to Pharmacokinetics  *
XU X., ZHOU S., YU Y. & CAI Y.  (1283)
 
 
Three New Similar Coordination Compounds: Crystal Structures and Anesthesia Activity Evaluation  *
LIU X.  (1288)
 
 
Drug Utilization Survey in Pediatric Outpatients of Karachi, Pakistan  *
NESAR S., RAHIM N., HUMA A., MUMTAZ T. & FATIMA B.  (1292)
 
 
Incorporation of Anticancer Drug into a Cu(II)-based Porous Metal-organic Framework: Drug Delivery and Inhibiting Human Cervical Cancer Cells  *
CHEN J., HUANG J. & LU E.  (1296)
 
 
Prostaglandin E1 Disturbs the Metabolic Elimination of acute Leukemia (AL) Treatment Drugs  *
SHAN X., SHAO Y., ZHOU M. & SUN N.  (1301)
 
 
Enhancement of Production of Pharmaceutical Compounds; Scopoletin and coumaric acid Via Yeast Extract Elicitation of Cell Culture of Althaea officinalis  *
YOUNESIKELAKI F.S., EBRAHIMZADEH M.H., YOUSEFI JAVAN I., RAHBARIAN R. & NANNA R.S.  (1304)
 
 
Protective Effects of Rutin on Hepatic Injury in Type 1 Diabetic  *
Mice YU Y., HAN T., QI Y., LI C. & BAI J.  (1308)
 
 
Anti-cancer Activity and Docking Studies of Pyran Derivatives  *
YU X.  (1315)
 
 
Two Novel Cytochalasins: Crystal Structures and Inhibition of Human Cancer Cells  *
LI X.  (1320)
 
 
Simultaneous Determination of the Plasma Concentrations of a Cocktail of 5 Cytochrome P450 Substrate Drugs and Their Metabolites by UPLC-MS/MS  *
TONG S., WU B., SONG H., LU X., YE L., HUANG B., WEN C. & WU Q.  (1324)
 
 
Assessments of Stability and Pharmacokinetics of Gambogenic Acid in Rats  *
SUN J., TANG X., XU Q., GE T., PENG D. & CHEN W.   (1333)
 
 
Anisodamine Inhibits Bleomycin-induced Pulmonary Fibrosis through Inhibition against Endoplasmic Reticulum Stress  *
LI M., QU W., WANG Z., DENG A. & CHEN J.  (1340)
 
 
Novel Naphthol Derivatives: Synthesis, Docking Studies and Inhibiting Human Glioma Cells  *
XIA K. & CHEN Q.  (1345)
 
 
Development and Validation of a New Spectrophotometric Method for the Determination of Regorafenib in Pure and Tablet Dosage Form  *
ALBAYRAK M.  (1349)
 
 
Effects of Berberine on Pharmacokinetics of Amlodipine in Rats and its Potential Mechanism  *
LIU L., GENG G., SUN S., LI P. & LI X.  (1354)
 
 
Pharmacokinetics and Tolerability of Intravenous Metadoxine in Healthy Chinese Volunteers: a Randomized, Open-Label, Single- and Multiple-Dose Study  *
ZHAO H., CAO R., FANG Z. & WANG H.  (1361)
 
 
Determination of AZD9291 (Osimertinib) in Rat Plasma by UPLC-MS/MS and its Application to Pharmacokinetic Study  *
HUA A., ZHOU Q., GENG P., WANG S., ZHOU Y. & YAN L.  (1366)
 
 
Application of a Water Stable Porous Metal-Organic Framework for 5-Fu Delivery and Anticancer Activity Study  *
HE F.  (1373)
 
 
Simple Validated Method for Theophylline Analysis at Kaolinite Modified Electrode  *
MAHESAR S.A., KAZI H.A., LAKHO S.A., KHASKHELI A.R., SIRAJUDDIN, SHERAZI S.T.H., SHAIKH T.H. & JAGIRANI M.S.  (1378)
 
 
Comparison of Outcomes Between Repeated and a Single Dose of Mifepristone in Combination with Misoprostol for Abortion: a Retrospective Cohort Study  *
SHI B., ZHU X., WANG H. & ZHU F.  (1383)
 
 
A New Microporous Er(III) Metal-Organic Framework for 5-Fu Loading and Inhibiting Human Glioma Cells  *
WANG D.  (1388)
 
 
Development of an UPLC-MS/MS Validated Method for Determination and Pharmacokinetic Study of Neratinib in Rat Plasma  *
HUANG P., HUA A., WANG S., ZHOU Q., WANG S., ZHOU Y. & LIU L.  (1392)
 
 
Analgesia of Intrathecal Injection of Tanshinone IIA to Rats With Neuropathic Pain and Changes of CGRP Gene Expression Levels  *
KUANG Z., LU W., DONG L., RAN Q. & WANG J.  (1399)
 
 
Comparison of Drug-Drug Interaction between Ochratoxin B and Ochratoxin C with Anaesthetic Drug Propofol  *
WU H., ZHANG L., ZENG K., CHEN L., HUANG J.  (1404)
 
 
Formulation and In Vitro Determination of Antifungal Activity of Ocimum basilicum L. (Maria Bonita cultivar) Essential Oils  *
ALMEIDA M.B., TRAVASSOS D.L., ANDRADE L., FERREIRA C.S., SEVERINO P., MOREIRA J.J.S., LIMA C.M., CRUZ E.M.O., TRINDADE R.C. & ARAÚJO E.D.  (1408)
 
 
Formulation Development and Optimization of Captopril Containing Tablets through BoxBehnken Design  *
AKHTAR M.F., HANIF M., MAJEED A. & SHAH S.  (1414)
 
 
Assessment of treatment response in patients taking antidepressant drugs sertraline and paroxetine  *
SARGANI M.H., GHOTO M.A., DAYO A., ARAIN M.I., PARVEEN R. & SALEEM R.  (1424)
 
 
Structure-Activity Relationships of Diverse Annonaceous Acetogenins (ACGs) Against Multidrug Resistant Human Breast Cancer Cell Line MCF-7/ADR  *
WANG X., LI Y., CHEN Y. & LI X.  (1429)
 
 
Thevetiaflavone Protects PC12 Cells Against Neurotoxicity Induced by Aβ1-42 Through Inhibiting Oxidative Stress and Activating Nrf2/HO-1 Pathway  *
YAO H., WEI P., WU H., LIU L., DUAN J., ZHANG C., LI Y. & YANG F.  (1437)
 
 
Novel 4-Arylpolyhydroquinoline Derivatives: Synthesis and Inhibition of Human Cervical Cancer Cells  *
XIE Y., SHI Q. & LI S.  (1443)
 
 
Assessment of Adherence And Its Contributing Factors Among Hypertension Patients In Eritrea  *
NURHUSSEIN L.K., DEBESAIM. & PREETH J.S.  (1448)
 
 
Anticholinesterase Activity of Extracts and Isolated Coumarins from Roots of Ferulago blancheana, F. pachyloba, F. trachycarpa and F. bracteata  *
KARAKAYA S., KOCA M., OKUYUCU M.B., KILIC C.S., OZBEK H., GUVENALP Z., DUMAN H. & KAZAZ C.  (1457)
 
 
Determination of Melaleuca alternifolia Cheel Essential Oil in Polymeric Nanocapsules Suspensions  *
MIRANTE D.C.,GONÇALVES M.M., JUSTUS B., DÖLL-BOSCARDIN P.M., BUDEL J.M., FARAGO P.V. & PAULA J.P.  (1463)
 
 
Antibacterial Activity of Curcumin and Solubility-Enhanced Curcumin in Microemulsion: a Comparative Study  *
SYED H.K. & PEH K.K.  (1468)
 
 
Preparation and Characterization of Stabilized Diclofenac Sodium W/O Microemulsion  *
AKHLAQ M., IQBAL S., AMANULLAH, ADEEL M. & IMRAN M.  (1478)
 



_________________

* English

** Portugûes

 
LOG-IN                                 

User


Password




Forgot your password?






ACTIONS ___     ___ _         

Submit Article

Check Manuscript Status

Suscription

Free Sample Issue



STATISTICS ___     ___        

JCR Impact Factor 2017:
0.401

Issues per year: 10

ISSN 0326 2383 (printed ed.)

ISSN 2362-3853 (on line ed.)
 




© Latin American Journal of Pharmacy 2018 | All rights reserved

Developed by: CAFFINI / COMMUNICATION & DESIGN